register

News & Trends - Pharmaceuticals

Boehringer Ingelheim’s dynamic evolution of ‘Life Forward’

Health Industry Hub | October 31, 2023 |

Pharma News: Boehringer Ingelheim has embarked on a transformative corporate rebrand, heralded by a vibrant new logo and a revitalised corporate colour palette. This shift encompasses not only a fresh visual identity but also the introduction of their inaugural brand slogan, Life Forward. The significance of this endeavour, as expressed by Boehringer’s Head of Corporate Affairs, extends far beyond a mere cosmetic alteration.

The company contemplates, “When future generations ask us to tell the story of how we tackled the most pressing challenges of our time, what will we say?”

This new direction takes root in the bedrock of the company’s overarching mission, encapsulated in the phrase ‘transforming lives for generations.’ It underscores how the corporation responds to the contemporary challenges of today and the unknown horizons of tomorrow, and the impact it aspires to create.

In a world grappling with non-communicable and infectious diseases, burgeoning aging populations, and healthcare systems pushed to their limits, the company takes on the task of addressing unmet medical needs. These critical areas encompass cardio-renal-metabolic (CRM) diseases, inflammation, oncology, and mental health.

Médard Schoenmaeckers, the Head of Corporate Affairs at Boehringer Ingelheim, firmly acknowledges the responsibility that comes with this role. “We have a responsibility to help address these challenges,” he stated. “Momentum to introduce our evolved brand has never been better with our well-stocked innovation pipeline that will make significant differences for both humans and animals.”

This evolution of the brand introduces a contemporary, digitally-driven brand experience. It takes inspiration from the company’s rich history as a family-owned enterprise, builds on their established record of pioneering collaborations, and amplifies their unwavering commitment to sustainability.

At the heart of this reimagined corporate brand lies a spirit of unwavering optimism. In everything we do and say, we look positively into the future because we know we can shape and influence it for the better and want to inspire others to join us,” added Mr Schoenmaeckers. “We have nearly 140 years of experience navigating the challenging dynamics of healthcare. And it is from that acquired resilience that we draw our confidence and the confidence that we can do better for the generations that come after us.”

Notably, other giants in the healthcare industry, such as Pfizer and the Johnson & Johnson Family of Companies, have also undertaken significant branding updates to remain in sync with the ever-evolving healthcare and consumer landscape.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.